Case number 2015-1456
Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ACORDA THERAPEUTICS INC. v. MYLAN PHARMACEUTICALS INC. [OPINION] [precedential] (0) |
| Jan 10, 2017 | 131 | The petition for writ of certiorari, [16-360], filed on 09/19/2016, was Denied on 01/09/2017. [397584] [15-1456, 15-1460] [CAB] [Entered: 01/10/2017 03:30 PM] (1) |
| Sep 26, 2016 | 130 | Petition for writ of Certiorari filed on 09/19/2016 in the Supreme Court of the United States. Supreme Court #: 16-360, Mylan Pharmaceuticals Inc. v. Acorda Therapeutics Inc. [369199] [15-1456, 15-1460] [CAB] [Entered: 09/26/2016 12:37 PM] (1) |
| Jun 27, 2016 | 129 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [346701] [CAB] [Entered: 06/27/2016 02:14 PM] (2) |
| Jun 20, 2016 | 128 | ORDER filed denying [106] petition for en banc rehearing filed by Mylan Pharmaceuticals Inc. and Mylan Inc. in 15-1456, and denying [327287-2] petition for en banc rehearing filed by Mylan Pharmaceuticals Inc. in 15-1460. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [345103] [15-1456, 15-1460] [CAB] [Entered: 06/20/2016 04:06 PM] (2) |
| May 31, 2016 | 127 | ORDER filed granting motions to withdraw attorney Thomas G. Sprankling [126] in 15-1456 and [338837-2] in 15-1460 filed by Amicus Curiae Pharmaceutical Research and Manufacturers of America. By: Per Curiam. Service as of this date by Clerk of Court. [339357] [15-1456, 15-1460] [CAB] [Entered: 05/31/2016 10:24 AM] (2) |
| May 26, 2016 | 126 | MOTION of Amicus Curiae Pharmaceutical Research and Manufacturers of America to withdraw counsel Thomas G. Sprankling. Response/Opposition is due 06/09/2016 [Consent: unopposed]. Service: 05/26/2016 by email. [338833] [Thomas Sprankling] [Entered: 05/26/2016 04:02 PM] (4) |
| May 19, 2016 | 125 | 16 paper copies of the response to the petition for en banc rehearing [124] received from Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited. [336887] [CAB] [Entered: 05/19/2016 03:44 PM] (0) |
| May 18, 2016 | 124 | RESPONSE of Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited to the petition for en banc rehearing [106] filed by Appellants Mylan Pharmaceuticals Inc. and Mylan Inc. in 15-1456. Service: 05/18/2016 by email. [336535] [Theodore Olson] [Entered: 05/18/2016 02:58 PM] (24) |
| May 10, 2016 | 123 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account(s) of Mark Pacella for Generic Pharmaceutical Association for Alkermes Pharma Ireland Limited. The e-mail address, (jtedrick@wileyrein.com), associated with your CM/ECF accounts has generated a delivery failure notice. Pursuant to Fed. Cir. R. 47.3(c)(1), counsel should promptly update their account information with the Pacer Service Center. [333662]--[Edited 05/11/2016 by clerk to correct docket text] [IW] [Entered: 05/10/2016 10:19 AM] (0) |
| May 5, 2016 | 121 | CORRECTED ORDER: correcting court order granting motion for leave to file an amicus curiae brief [331634-2]]; reason(s): to include 15-1456 in the Order. Service as of this date by Clerk of Court. [332404] [15-1456, 15-1460] [CAB] [Entered: 05/05/2016 09:50 AM] (2) |
| May 5, 2016 | 122 | AMICUS BRIEF FILED on Petition for Generic Pharmaceutical Association [117]. Pages: 10. [332427] [CAB] [Entered: 05/05/2016 10:17 AM] (17) |
| May 3, 2016 | 118 | Corrected Entry of appearance for Wesley E. Weeks as of counsel for Generic Pharmaceutical Association. Service: 05/02/2016 by email. [331852] [Wesley Weeks] [Entered: 05/03/2016 04:55 PM] (2) |
| May 3, 2016 | 119 | CORRECTED certificate of service Generic Pharmaceutical Association for attorney entry of appearance , Doc No. [113]. Service: 05/03/2016 by email. [331864] [James Wallace] [Entered: 05/03/2016 05:28 PM] (1) |
| May 3, 2016 | 120 | CORRECTED certificate of service Generic Pharmaceutical Association for attorney entry of appearance , Doc No. [114]. Service: 05/03/2016 by email. [331866] [Mark Pacella] [Entered: 05/03/2016 05:32 PM] (1) |
| May 2, 2016 | 112 | ORDER filed granting motion to withdraw attorney DAVID ZACHARY HUDSON [111] [330769-2] filed by Appellants Mylan Pharmaceuticals Inc. and Mylan Inc. in 15-1456, and by Appellant Mylan Pharmaceuticals Inc. in 15-1460. By: Court (Per Curiam). Service as of this date by Clerk of Court. [330955] [15-1456, 15-1460] [AT] [Entered: 05/02/2016 08:03 AM] (2) |
| May 2, 2016 | 113 | Entry of appearance for James H. Wallace, Jr. as principal counsel for Generic Pharmaceutical Association. Service: 05/02/2016 by email. [331418] [James Wallace] [Entered: 05/02/2016 07:42 PM] (1) |
| May 2, 2016 | 114 | Entry of appearance for Mark A. Pacella as of counsel for Generic Pharmaceutical Association. Service: 05/02/2016 by email. [331420] [Mark Pacella] [Entered: 05/02/2016 07:44 PM] (1) |
| May 2, 2016 | 115 | Entry of appearance for Wesley E. Weeks as of counsel for Generic Pharmaceutical Association. Service: 05/02/2016 by email. [331421] [Wesley Weeks] [Entered: 05/02/2016 07:46 PM] (1) |
| May 2, 2016 | 116 | MOTION of Generic Pharmaceutical Association for leave to file amicus brief in support of Defendants-Appellants Mylan Pharmaceuticals Inc. and Mylan Inc. on petition for en banc rehearing [106]. Response/Opposition is due 05/16/2016 [Consent: unopposed]. Service: 05/02/2016 by email. [331423] [Wesley Weeks] [Entered: 05/02/2016 07:53 PM] (5) |
| May 2, 2016 | 117 | TENDERED from Generic Pharmaceutical Association Title: AMICUS CURIAE BRIEF. Service: 05/02/2016 by email. [331424] [Wesley Weeks] [Entered: 05/02/2016 07:55 PM] (17) |
| Apr 29, 2016 | 111 | MOTION of Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. to withdraw counsel David Zachary Hudson. Response/Opposition is due 05/12/2016 [Consent: not addressed]. Service: 04/29/2016 by email. [330766] [Paul Clement] [Entered: 04/29/2016 02:03 PM] (4) |
| Apr 22, 2016 | 110 | ORDER filed granting motion to extend time to file a response to en banc/rehearing petition [328472-2] filed by Appellee Astrazeneca AB in 15-1460; extending the time to file a response to the petition for rehearing en banc until 05/18/2016 in 15-1456. By: (Per Curiam). Service as of this date by Clerk of Court. [328718] [15-1460, 15-1456] [SJ] [Entered: 04/22/2016 09:27 AM] (2) |
| Apr 20, 2016 | 108 | The court invites responses from Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited to the petition for en banc rehearing filed by Appellants in 15-1456. Responses are due by May 4, 2016. [327937] [AT] [Entered: 04/20/2016 10:15 AM] (1) |
| Apr 20, 2016 | 109 | 18 paper copies of the petition for en banc rehearing [106] received from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. [327947] [AT] [Entered: 04/20/2016 10:24 AM] (0) |
| Apr 19, 2016 | 107 | Entry of appearance for George W. Hicks, Jr. as of counsel for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 04/19/2016 by email. [327403] [George Hicks] [Entered: 04/19/2016 09:04 AM] (1) |
| Apr 18, 2016 | 106 | Petition for en banc rehearing filed by Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 04/18/2016 by email. The paper copies of the petition must be filed within two business days (see ECF-10(d)).The required paper copies should be received by the court on or before 04/20/2016 [327283] [Paul Clement] [Entered: 04/18/2016 04:37 PM] (58) |
| Mar 18, 2016 | 105 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Newman,Circuit Judge; O'Malley,Circuit Judge and Taranto,Circuit Judge). Opinion concurring in the judgment filed by Circuit Judge O'Malley. [319890] [15-1456, 15-1460] [CAB] [Entered: 03/18/2016 09:14 AM] (38) |
| Mar 11, 2016 | 104 | RESPONSE of Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited to the supplemental authority [103] filed by Appellants Mylan Pharmaceuticals Inc. and Mylan Inc. in 15-1456. Service: 03/11/2016 by email. [318061] [Amir Tayrani] [Entered: 03/11/2016 04:50 PM] (3) |
| Mar 10, 2016 | 103 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 03/10/2016 by email. [317629] [Paul Clement] [Entered: 03/10/2016 05:24 PM] (38) |
| Feb 23, 2016 | 102 | RESPONSE of Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited to the supplemental authority [101] filed by Appellants Mylan Pharmaceuticals Inc. and Mylan Inc. in 15-1456. Service: 02/23/2016 by email. [313405] [Theodore Olson] [Entered: 02/23/2016 04:32 PM] (3) |
| Feb 22, 2016 | 101 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 02/22/2016 by email. [313024] [Paul Clement] [Entered: 02/22/2016 04:37 PM] (56) |
| Jan 4, 2016 | 100 | Submitted after ORAL ARGUMENT by Paul D. Clement, Esq. for Mylan Pharmaceuticals Inc. and Mylan Inc. and Theodore B. Olson, Esq. for Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited. Panel: Judge: Newman , Judge: O'Malley , Judge: Taranto. [299793] [JAB] [Entered: 01/04/2016 10:35 AM] (0) |
| Dec 11, 2015 | 99 | Response to oral argument order from the Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. designating Paul D. Clement as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [295588] [Paul Clement] [Entered: 12/11/2015 04:02 PM] (0) |
| Dec 8, 2015 | 98 | Clerk's Letter to Appellee Acorda Therapeutics Inc. (Clerk's letter regarding conflicts with oral argument scheduling). See related entry: [95]. Service as of this date by Clerk of Court. [294464] [JAB] [Entered: 12/08/2015 10:51 AM] (1) |
| Nov 30, 2015 | 97 | Response to oral argument order from the Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited. designating Theodore B. Olson as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [292424] [Theodore Olson] [Entered: 11/30/2015 06:14 PM] (0) |
| Nov 20, 2015 | 96 | NOTICE OF CALENDARING. Panel: 1601A. Case scheduled Jan 04, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 12/15/2015. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [290564] THIS NOTICE APPLIES TO CASE(S): [15-1456, 15-1460] [JAB] [Entered: 11/20/2015 02:51 PM] (0) |
| Nov 19, 2015 | 95 | Notice from Appellee Acorda Therapeutics Inc. regarding conflicts with oral argument (January 4-8, March 7-8, April 6-8, 2016). Service: 11/19/2015 by email. [290253] [Theodore Olson] [Entered: 11/19/2015 06:49 PM] (1) |
| Oct 27, 2015 | 94 | Notice from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. regarding conflicts with oral argument (01/06/2016 - 01/08/2016; 02/01/2016 - 02/05/2016). Service: 10/27/2015 by email. [283705] [Paul Clement] [Entered: 10/27/2015 11:42 AM] (4) |
| Sep 3, 2015 | 92 | Notice from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. regarding conflicts with oral argument (October 5-9, 2015 and December 7-11, 2015). Service: 09/03/2015 by email. [269368] [Paul Clement] [Entered: 09/03/2015 01:31 PM] (1) |
| Sep 3, 2015 | 93 | Notice from Appellee Acorda Therapeutics Inc. regarding conflicts with oral argument (November 5-6, 2015). Service: 09/03/2015 by email. [269574] [Theodore Olson] [Entered: 09/03/2015 06:51 PM] (1) |
| Aug 17, 2015 | 89 | ORDER granting motion to withdraw attorney [88] filed by Amicus Curiae Chamber of Commerce of the United States of America. Service as of this date by Clerk of Court. [264588] [SJ] [Entered: 08/17/2015 11:45 AM] (2) |
| Aug 17, 2015 | 90 | 6 paper copies of the appendix Brief [87] received from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. [266696] [LAJ] [Entered: 08/25/2015 01:52 PM] (0) |
| Aug 17, 2015 | 91 | 6 paper copies of the Reply Brief [86] received from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. [266699] [LAJ] [Entered: 08/25/2015 01:54 PM] (0) |
| Aug 14, 2015 | 88 | MOTION of Amicus Curiae Chamber of Commerce of the United States of America to withdraw counsel James F. Tierney. Response/Opposition is due 08/27/2015 [Consent: unopposed]. Service: 08/14/2015 by email. [264248] [James Tierney] [Entered: 08/14/2015 12:08 PM] (3) |
| Aug 12, 2015 | 84 | Certificate of Interest for the Amicus Curiae Biotechnology Industry Organization. Service: 08/12/2015 by email. [263545] [Christopher Glancy] [Entered: 08/12/2015 12:32 PM] (2) |
| Aug 12, 2015 | 85 | Amended Certificate of Interest for the Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 08/12/2015 by email. [263706] [Paul Clement] [Entered: 08/12/2015 05:12 PM] (3) |
| Aug 11, 2015 | 83 | TENDERED from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Title: JOINT APPENDIX. Service: 08/11/2015 by email. [263304] [Paul Clement] [Entered: 08/11/2015 03:41 PM] (125) |
| Aug 11, 2015 | 87 | APPENDIX FILED for Mylan Inc. and Mylan Pharmaceuticals Inc. [83]. Number of Pages: 125. Service: 08/11/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/18/2015. [263945] [SJ] [Entered: 08/13/2015 03:00 PM] (125) |
| Aug 10, 2015 | 82 | TENDERED from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Title: REPLY BRIEF. Service: 08/10/2015 by email. [263053] [Paul Clement] [Entered: 08/10/2015 03:34 PM] (38) |
| Aug 10, 2015 | 86 | REPLY BRIEF FILED for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. [82]. Number of Pages: 29. Service: 08/10/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/18/2015. Appendix is due 08/20/2015. [263938] [SJ] [Entered: 08/13/2015 02:49 PM] (38) |
| Jul 29, 2015 | 81 | 6 paper copies of the Amicus Brief [78] received from Amici Curiae Thomas C. Arthur, Lisa A. Dolak, Richard D. Freer and Megan M. La Belle. [261907] [CAB] [Entered: 08/04/2015 04:33 PM] (0) |
| Jul 28, 2015 | 80 | 6 paper copies of the Amicus Brief [72] received from Amici Curiae Pharmaceutical Research and Manufacturers of America, and 6 paper copies of the Amicus Brief [71] received from Amici Curiae Biotechnology Industry Organization. [261906] [CAB] [Entered: 08/04/2015 04:32 PM] (0) |
| Jul 27, 2015 | 79 | 6 paper copies of the Amicus Brief [70] received from Amicus Curiae Teva Pharmaceuticals USA, Inc. [261902] [CAB] [Entered: 08/04/2015 04:27 PM] (0) |
| Jul 24, 2015 | 69 | Certificate of Interest for the Amicus Curiae Pharmaceutical Research and Manufacturers of America. Service: 07/24/2015 by email. [259324] [Kevin Prussia] [Entered: 07/24/2015 02:22 PM] (1) |
| Jul 24, 2015 | 73 | NOTICE OF REJECTION: The brief of Amici Curiae Thomas C. Arthur, Lisa A. Dolak, Richard D. Freer and Megan M. La Belle (Brief of Amici Curiae in Support of Appellees) [57], is not in compliance with the rules of this court and is therefore rejected for filing. Amicus brief due 08/07/2015. Service as of this date by Clerk of Court. [259341] [CAB] [Entered: 07/24/2015 02:45 PM] (3) |
| Jul 24, 2015 | 74 | Certificate of Interest for the Amicus Curiae Teva Pharmaceuticals USA, Inc.. Service: 07/24/2015 by email. [259377] [William Jay] [Entered: 07/24/2015 04:04 PM] (2) |
| Jul 24, 2015 | 76 | Certificate of Interest for the Amici Curiae Thomas C. Arthur, Lisa A. Dolak, Richard D. Freer and Megan M. La Belle. Service: 07/24/2015 by email. [259393] [Carter Phillips] [Entered: 07/24/2015 04:23 PM] (2) |
| Jul 24, 2015 | 77 | TENDERED from Amici Curiae Thomas C. Arthur, Lisa A. Dolak, Richard D. Freer and Megan M. La Belle. Title: CORRECTED AMICUS CURIAE BRIEF. Service: 07/24/2015 by email. [259398] [Carter Phillips] [Entered: 07/24/2015 04:26 PM] (29) |
| Jul 24, 2015 | 78 | CORRECTED AMICUS BRIEF FILED for Thomas C. Arthur, Lisa A. Dolak, Richard D. Freer and Megan M. La Belle [77]. Number of Pages: 19. Service: 07/24/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/03/2015. [260085] [CAB] [Entered: 07/28/2015 04:40 PM] (29) |
| Jul 23, 2015 | 53 | Entry of appearance for Edmund G. LaCour Jr. as of counsel for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 07/23/2015 by email. [258699] [Edmund LaCour] [Entered: 07/23/2015 09:27 AM] (1) |
| Jul 23, 2015 | 54 | Entry of appearance for Carter G. Phillips as principal counsel for Thomas C. Arthur and Richard D. Freer, Emory University School of Law; Lisa A. Dolak, Syracuse University College of Law; and Megan M. La Belle, Catholic University of America, Columbus School of Law. Service: 07/23/2015 by email. [258878] [Carter Phillips] [Entered: 07/23/2015 02:38 PM] (2) |
| Jul 23, 2015 | 55 | Entry of appearance for Ryan C. Morris as of counsel for Thomas C. Arthur and Richard D. Freer, Emory University School of Law; Lisa A. Dolak, Syracuse University College of Law; and Megan M. La Belle, Catholic University of America, Columbus School of Law. Service: 07/23/2015 by email. [258880] [Carter Phillips] [Entered: 07/23/2015 02:40 PM] (2) |
| Jul 23, 2015 | 56 | Entry of appearance for Anna M. Weinberg as of counsel for Thomas C. Arthur and Richard D. Freer, Emory University School of Law; Lisa A. Dolak, Syracuse University College of Law; and Megan M. La Belle, Catholic University of America, Columbus School of Law. Service: 07/23/2015 by email. [258881] [Carter Phillips] [Entered: 07/23/2015 02:41 PM] (2) |
| Jul 23, 2015 | 57 | TENDERED from Thomas C. Arthur and Richard D. Freer, Emory University School of Law; Lisa A. Dolak, Syracuse University College of Law; and Megan M. La Belle, Catholic University of America, Columbus School of Law Title: AMICUS CURIAE BRIEF. Service: 07/23/2015 by email. [258989] This brief has been rejected. See Doc No. [73] [Carter Phillips] [Entered: 07/23/2015 05:02 PM] (0) |
| Jul 23, 2015 | 58 | Entry of appearance for William M. Jay as principal counsel for Teva Pharmaceuticals USA, Inc.. Service: 07/23/2015 by email. [259004] [William Jay] [Entered: 07/23/2015 06:08 PM] (2) |
| Jul 23, 2015 | 59 | Entry of appearance for Brian T. Burgess as of counsel for Teva Pharmaceuticals USA, Inc.. Service: 07/23/2015 by email. [259006] [Brian Burgess] [Entered: 07/23/2015 06:12 PM] (2) |
| Jul 23, 2015 | 60 | TENDERED from Teva Pharmaceuticals USA, Inc. Title: AMICUS CURIAE BRIEF. Service: 07/23/2015 by email. [259008] [William Jay] [Entered: 07/23/2015 06:19 PM] (34) |
| Jul 23, 2015 | 61 | Entry of appearance for Christopher J. Glancy as principal counsel for BIOTECHNOLOGY INDUSTRY ORGANIZATION. Service: 07/23/2015 by email. [259020] [Christopher Glancy] [Entered: 07/23/2015 08:11 PM] (2) |
| Jul 23, 2015 | 62 | Entry of appearance for Adam R. Gahtan as of counsel for BIOTECHNOLOGY INDUSTRY ORGANIZATION. Service: 07/23/2015 by email. [259021] [Christopher Glancy] [Entered: 07/23/2015 08:12 PM] (2) |
| Jul 23, 2015 | 63 | TENDERED from BIOTECHNOLOGY INDUSTRY ORGANIZATION Title: AMICUS CURIAE BRIEF. Service: 07/23/2015 by email. [259022] [Christopher Glancy] [Entered: 07/23/2015 08:13 PM] (18) |
| Jul 23, 2015 | 64 | Entry of appearance for David W. Ogden as principal counsel for Pharmaceutical Research and Manufacturers of America. Service: 07/23/2015 by email. [259023] [Thomas Saunders] [Entered: 07/23/2015 08:17 PM] (1) |
| Jul 23, 2015 | 65 | Entry of appearance for Thomas G. Saunders as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 07/23/2015 by email. [259024] [Thomas Saunders] [Entered: 07/23/2015 08:19 PM] (1) |
| Jul 23, 2015 | 66 | Entry of appearance for Thomas G. Sprankling as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 07/23/2015 by email. [259026] [Thomas Sprankling] [Entered: 07/23/2015 08:22 PM] (1) |
| Jul 23, 2015 | 67 | Entry of appearance for Kevin S. Prussia as of counsel for Pharmaceutical Research and Manufacturers of America. Service: 07/23/2015 by email. [259027] [Kevin Prussia] [Entered: 07/23/2015 08:25 PM] (1) |
| Jul 23, 2015 | 68 | TENDERED from Pharmaceutical Research and Manufacturers of America Title: AMICUS CURIAE BRIEF. Service: 07/23/2015 by email. [259029] [Kevin Prussia] [Entered: 07/23/2015 08:41 PM] (31) |
| Jul 23, 2015 | 70 | AMICUS BRIEF FILED for Teva Pharmaceuticals USA, Inc. [60]. Number of Pages: 25. Service: 07/23/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/29/2015. [259337] [CAB] [Entered: 07/24/2015 02:32 PM] (34) |
| Jul 23, 2015 | 71 | AMICUS BRIEF FILED for Biotechnology Industry Organization [63]. Number of Pages: 11. Service: 07/23/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/29/2015. [259338] [CAB] [Entered: 07/24/2015 02:35 PM] (18) |
| Jul 23, 2015 | 72 | AMICUS BRIEF FILED for Pharmaceutical Research and Manufacturers of America [68]. Number of Pages: 22. Service: 07/23/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/29/2015. [259339] [CAB] [Entered: 07/24/2015 02:38 PM] (31) |
| Jul 22, 2015 | 75 | 6 paper copies of the Opening Response Brief [52] received from Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited. [259392] [CAB] [Entered: 07/24/2015 04:20 PM] (0) |
| Jul 16, 2015 | 51 | TENDERED from Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited. Title: RESPONSE BRIEF. Service: 07/16/2015 by email. [256933] [Theodore Olson] [Entered: 07/16/2015 04:10 PM] (64) |
| Jul 16, 2015 | 52 | BRIEF FILED for Appellee Acorda Therapeutics Inc. [51]. Number of Pages: 51. Service: 07/16/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/27/2015. [257606] [CAB] [Entered: 07/20/2015 12:03 PM] (64) |
| Jul 8, 2015 | 50 | ORDER granting motion to withdraw Harker Rhodes as counsel of record [49] for Appellants Mylan Pharmaceuticals Inc. and Mylan Inc. Service: 07/08/2015 by clerk. [254477] [LMS] [Entered: 07/08/2015 09:34 AM] (2) |
| Jun 30, 2015 | 49 | MOTION of Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. to withdraw counsel C. Harker Rhodes IV. Response/Opposition is due 07/13/2015 [Consent: not addressed]. Service: 06/30/2015 by email. [252392] [C. Harker Rhodes] [Entered: 06/30/2015 09:56 AM] (2) |
| Jun 24, 2015 | 48 | ORDER granting motion to extend time to file appellees' principal brief [45] and granting motion to extend time to file appellants' reply brief [45] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Appellees Alkermes Pharma Ireland Limited and Acorda Therapeutics Inc. The appellees' principal brief is due July 16, 2015 and the appellants' reply brief is due August 10, 2015. Service: 06/24/2015 by clerk. [251178] [LMS] [Entered: 06/24/2015 03:29 PM] (2) |
| Jun 16, 2015 | 47 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account(s) of Theodore B. Olson, Esq. for Acorda Therapeutics Inc.. One or more e-mail addresses associated with your CM/ECF account, (ezimmerman@gibsondunn.com), is invalid and has been returned as undeliverable. Pursuant to ECF-2(E) of the Administrative Order Regarding Electronic Case Filing, an ECF filer must update all contact information with the Pacer Service Center. [248689] [IW] [Entered: 06/16/2015 09:42 AM] (0) |
| Jun 15, 2015 | 43 | Notice to counsel for Amicus Curiae Chamber of Commerce of the United States of America: The record of this case indicates that the Certificate of Interest has not been filed. A completed certificate of Interest must be submitted in accordance with Fed. Cir. R. 47.4 by 06/16/2015.. Service as of this date by Clerk of Court. [248207] [SJ] [Entered: 06/15/2015 09:58 AM] (0) |
| Jun 15, 2015 | 44 | Certificate of Interest for the Amicus Curiae Chamber of Commerce of the United States of America. Service: 06/15/2015 by email. [248570] [Andrew Pincus] [Entered: 06/15/2015 05:26 PM] (2) |
| Jun 15, 2015 | 45 | MOTION of Appellants Mylan Inc., Mylan Pharmaceuticals Inc. and Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited to extend the time to 07/16/2015 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 06/29/2015, to extend the time to 08/10/2015 to file the reply brief. Response/Opposition is due 06/29/2015 [Consent: unopposed]. Service: 06/15/2015 by email. [248594] [Theodore Olson] [Entered: 06/15/2015 08:01 PM] (8) |
| May 29, 2015 | 46 | 6 paper copies of the Amicus Brief [41] received from Amicus Curiae Chamber of Commerce of the United States of America. [248647] [CAB] [Entered: 06/16/2015 08:49 AM] (0) |
| May 26, 2015 | 36 | Entry of appearance for Andrew J. Pincus as principal counsel for The Chamber of Commerce of the United States. Service: 05/26/2015 by email. [243709] [Andrew Pincus] [Entered: 05/26/2015 07:53 PM] (2) |
| May 26, 2015 | 37 | Entry of appearance for Paul W. Hughes as of counsel for The Chamber of Commerce of the United States. Service: 05/26/2015 by email. [243714] [Paul Hughes] [Entered: 05/26/2015 07:58 PM] (2) |
| May 26, 2015 | 38 | Entry of appearance for James F. Tierney as of counsel for The Chamber of Commerce of the United States. Service: 05/26/2015 by email. [243718] [James Tierney] [Entered: 05/26/2015 08:04 PM] (2) |
| May 26, 2015 | 39 | Entry of appearance for Kate Comerford Todd as of counsel for The Chamber of Commerce of the United States. Service: 05/26/2015 by email. [243720] [Kathryn Todd] [Entered: 05/26/2015 08:09 PM] (2) |
| May 26, 2015 | 40 | TENDERED from The Chamber of Commerce of the United States Title: AMICUS CURIAE BRIEF. Service: 05/26/2015 by email. [243726] [Andrew Pincus] [Entered: 05/26/2015 08:19 PM] (34) |
| May 26, 2015 | 41 | AMICUS BRIEF FILED for Chamber of Commerce of the United States of America [40]. Number of Pages: 23. Service: 05/26/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/01/2015. [244092] [CAB] [Entered: 05/27/2015 04:31 PM] (34) |
| May 26, 2015 | 42 | 6 paper copies of the Opening Brief [35] received from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. [246997] [CAB] [Entered: 06/09/2015 04:54 PM] (0) |
| May 22, 2015 | 34 | TENDERED from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Title: CORRECTED OPENING BRIEF. Service: 05/22/2015 by email. [242978] [Paul Clement] [Entered: 05/22/2015 12:16 PM] (111) |
| May 22, 2015 | 35 | CORRECTED BRIEF FILED for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. [34]. Number of Pages: 53. Service: 05/22/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/27/2015. [243053] [CAB] [Entered: 05/22/2015 02:04 PM] (111) |
| May 21, 2015 | 31 | NOTICE OF REJECTION: The brief of Appellants Mylan Inc. and Mylan Pharmaceuticals Inc., Opening Brief [29], is not in compliance with the rules of this court and is therefore rejected for filing. Brief due 06/04/2015. Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited brief is due 07/02/2015. Service as of this date by Clerk of Court. [242662] [KJ] [Entered: 05/21/2015 12:22 PM] (2) |
| May 21, 2015 | 32 | Notice to counsel for Appellee Alkermes Pharma Ireland Limited: The record of this case indicates that the Docketing Statement has not been filed. Docketing Statement due 06/01/2015. Service as of this date by Clerk of Court. [242679] [KJ] [Entered: 05/21/2015 12:41 PM] (0) |
| May 21, 2015 | 33 | Docketing Statement for the Appellee Alkermes Pharma Ireland Limited. Service: 05/21/2015 by email. [242736] [Jeremy Tigan] [Entered: 05/21/2015 02:52 PM] (3) |
| May 20, 2015 | 30 | Note to file: Appeals 15-1460 and 15-1456 appear to be related. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [242274] [15-1460, 15-1456] [AT] [Entered: 05/20/2015 11:32 AM] (0) |
| May 18, 2015 | 29 | TENDERED from Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Title: OPENING BRIEF. Service: 05/18/2015 by email. [241777]. This brief has been rejected. See Doc No. [31] [Paul Clement] [Entered: 05/18/2015 06:58 PM] (0) |
| Mar 31, 2015 | 28 | Docketing Statement for the Appellee Acorda Therapeutics Inc.. Service: 03/31/2015 by email. [228125] [Theodore Olson] [Entered: 03/31/2015 07:48 AM] (3) |
| Mar 30, 2015 | 27 | Entry of appearance for C. Harker Rhodes IV as of counsel for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 03/30/2015 by email. [227956] [C. Harker Rhodes] [Entered: 03/30/2015 01:52 PM] (2) |
| Mar 27, 2015 | 25 | Certificate of Interest for the Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 03/27/2015 by email. [227597] [Paul Clement] [Entered: 03/27/2015 10:47 AM] (3) |
| Mar 27, 2015 | 26 | Docketing Statement for the Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 03/27/2015 by email. [227602] [Paul Clement] [Entered: 03/27/2015 10:52 AM] (3) |
| Mar 23, 2015 | 23 | Filing fee paid in the United States District Court for the District of Delaware on 03/19/2015. [226169] [SW] [Entered: 03/23/2015 10:32 AM] (0) |
| Mar 23, 2015 | 24 | Copy of Order from United States District Court for the District of Delaware Proof of payment of filing fee and docket report.. [226172] [SW] [Entered: 03/23/2015 10:34 AM] (18) |
| Mar 19, 2015 | 21 | Entry of appearance for Paul D. Clement as principal counsel for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 03/19/2015 by email. [225760] [Paul Clement] [Entered: 03/19/2015 09:18 PM] (2) |
| Mar 19, 2015 | 22 | Entry of appearance for D. Zachary Hudson as of counsel for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 03/19/2015 by email. [225761] [David Hudson] [Entered: 03/19/2015 09:22 PM] (2) |
| Mar 18, 2015 | 6 | Corrected Entry of appearance for Theodore B. Olson as principal counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225150] [Theodore Olson] [Entered: 03/18/2015 09:04 AM] (1) |
| Mar 18, 2015 | 7 | Corrected Entry of appearance for Jane G. Wasman as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225152] [Jane Wasman] [Entered: 03/18/2015 09:09 AM] (1) |
| Mar 18, 2015 | 8 | Entry of appearance for Amir C. Tayrani as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225193] [Amir Tayrani] [Entered: 03/18/2015 10:18 AM] (1) |
| Mar 18, 2015 | 9 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [5] filed by Appellee Acorda Therapeutics Inc. in 15-1456 , attorney entry of appearance Document No. [4] filed by Appellee Acorda Therapeutics Inc. in 15-1456 , attorney entry of appearance Document No. [3] filed by Appellee Acorda Therapeutics Inc. in 15-1456 are not text searchable and therefore cannot be accepted for filing at this time. Corrected documents have been filed with the court. [225204] [SW] [Entered: 03/18/2015 10:35 AM] (0) |
| Mar 18, 2015 | 10 | Entry of appearance for Aaron Stiefel as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225309] [Aaron Stiefel] [Entered: 03/18/2015 02:13 PM] (2) |
| Mar 18, 2015 | 11 | Entry of appearance for Maryellen Noreika as principal counsel for Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited. Service: 03/18/2015 by email. [225334] [Maryellen Noreika] [Entered: 03/18/2015 02:54 PM] (2) |
| Mar 18, 2015 | 12 | Entry of appearance for Jack B. Blumenfeld as of counsel for Appellees Acorda Therapeutics Inc. and Alkermes Pharma Ireland Limited. Service: 03/18/2015 by email. [225335] [Maryellen Noreika] [Entered: 03/18/2015 02:56 PM] (2) |
| Mar 18, 2015 | 13 | Entry of appearance for Jeremy A. Tigan as of counsel for Appellee Alkermes Pharma Ireland Limited. Service: 03/18/2015 by email. [225336] [Maryellen Noreika] [Entered: 03/18/2015 02:57 PM] (2) |
| Mar 18, 2015 | 14 | Certificate of Interest for the Appellee Alkermes Pharma Ireland Limited. Service: 03/18/2015 by email. [225339] [Maryellen Noreika] [Entered: 03/18/2015 02:59 PM] (2) |
| Mar 18, 2015 | 15 | Entry of appearance for Daniel P. DiNapoli as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225367] [Daniel DiNapoli] [Entered: 03/18/2015 03:24 PM] (2) |
| Mar 18, 2015 | 16 | Entry of appearance for Sylvia Becker as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225374] [Sylvia Becker] [Entered: 03/18/2015 03:29 PM] (2) |
| Mar 18, 2015 | 17 | Entry of appearance for Anthony Michael as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225380] [Anthony Michael] [Entered: 03/18/2015 03:33 PM] (2) |
| Mar 18, 2015 | 18 | Entry of appearance for Soumitra Deka as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225385] [Soumitra Deka] [Entered: 03/18/2015 03:38 PM] (2) |
| Mar 18, 2015 | 19 | Entry of appearance for Jeffrey Martin as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225387] [Jeffrey Martin] [Entered: 03/18/2015 03:45 PM] (2) |
| Mar 18, 2015 | 20 | Certificate of Interest for the Appellee Acorda Therapeutics Inc.. Service: 03/18/2015 by email. [225427] [Theodore Olson] [Entered: 03/18/2015 05:11 PM] (2) |
| Mar 17, 2015 | 1 | Appeal docketed pursuant to the court's order in Misc. No. 15-124. [224919]Fee/IFP due on 03/31/2015. Entry of Appearance due 03/31/2015. Certificate of Interest is due on 03/31/2015. Docketing Statement due 03/31/2015. Appellants brief due 05/18/2015. [AT] [Entered: 03/17/2015 12:30 PM] (4) |
| Mar 17, 2015 | 2 | Clerk's notice to United States District Court for the District of Delaware: The petition for permission to appeal for Appellants Mylan Inc. and Mylan Pharmaceuticals Inc. (Misc. No. 15-124) has been granted. Please forward to this court the certified list and proof of payment of the filing fee. Service as of this date by Clerk of Court. [224923] [AT] [Entered: 03/17/2015 12:33 PM] (1) |
| Mar 17, 2015 | 3 | Entry of appearance for Theodore B. Olson as principal counsel for Appellee Acorda Therapeutics Inc.. Service: 03/17/2015 by email. [225104] [Theodore Olson] [Entered: 03/17/2015 05:32 PM] (0) |
| Mar 17, 2015 | 4 | Entry of appearance for Jane G. Wasman as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/17/2015 by email. [225105] [Theodore Olson] [Entered: 03/17/2015 05:33 PM] (0) |
| Mar 17, 2015 | 5 | Entry of appearance for Jane G. Wasman as of counsel for Appellee Acorda Therapeutics Inc.. Service: 03/17/2015 by email. [225106] [Jane Wasman] [Entered: 03/17/2015 05:36 PM] (0) |
